July 06, 2022
Previous attempts to make associations between JIA and prenatal maternal infection is difficult due to the rarity of JIA diagnosis and recall bias.
July 06, 2022
Many people now use activity trackers to assess their activity levels, but what role can these devices play in managing rheumatoid arthritis patients? Test your knowledge with this quiz.
July 01, 2022
“The differential contribution of IL-6 and IL-17 pathways to the pathogenesis of psoriatic arthritis is not fully understood,” investigators stated.
June 30, 2022
Take a few minutes to check out Rheumatology Network's top expert interviews from Q2 2022.
June 29, 2022
The approval and implementation of new drugs can vastly improve quality of life and reduce signs and symptoms of disease burden in patients with rheumatic and dermatologic diseases.
June 28, 2022
The Committee for Medicinal Products for Human Use (CHMP) recommends approving upadacitinib 15 mg, once daily, for the treatment of active non-radiographic axial spondyloarthritis in adults patients with inflammation and inadequate response to NSAIDs.
June 28, 2022
Take a few minutes to discover Rheumatology Network's most-viewed EULAR 2022 coverage.
June 27, 2022
The approvals were based on results from the JUNIPERA trial, which showed secukinumab reduced the risk of flare and disease activity when compared with placebo over 2 years in pediatric patients with ERA and JPsA.
June 27, 2022
"The challenges of an existing rheumatologist workforce shortage, changing workforce demographics, and physician burnout have been compounded by the COVID-19 pandemic."
June 25, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 25, 2022.